You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 230 Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer (ANNIE): a multicenter, single-arm, phase 2 trial

Article metrics

Article menu

Download PDFPDF

Ovarian cancer
230 Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer (ANNIE): a multicenter, single-arm, phase 2 trial
Free

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2023

AbstractFullPdf
Dec 202050013
Jan 20213507
Feb 20211807
Mar 202141015
Apr 202134014
May 20211007
Jun 2021006
Jul 2021002
Aug 2021003
Sep 20210010
Oct 202132017
Nov 202128019
Dec 20211604
Jan 20224006
Feb 20222803
Mar 20224002
Apr 20222207
May 20222609
Jun 20221404
Jul 20222704
Aug 20221408
Sep 20222506
Oct 202234010
Nov 20221606
Dec 20223604
Jan 20232005
Feb 20231205
Mar 20231003
Total6280206